1 / 27

LabStyle Innovations Corp. ( OTCQB:DRIOD)

Thriving with Diabetes In the mHealth Era. LabStyle Innovations Corp. ( OTCQB:DRIOD). Disclaimer Regarding Forward-Looking Statements

montague-santos
Download Presentation

LabStyle Innovations Corp. ( OTCQB:DRIOD)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Thriving with DiabetesIn the mHealthEra LabStyle Innovations Corp. (OTCQB:DRIOD)

  2. Disclaimer Regarding Forward-Looking Statements This presentation of LabStyle Innovations Corp. (the “Company”) and statements of the Company’s management or agents related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act").  Words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions all denote forward-looking statements within the meaning of the Act.  Factors that could cause or contribute to such differences include the Company’s compliance with regulatory requirements, the Company’s status as a new public company, the impact of current and any future competition, as well as other factors and risks discussed in the Company's filings with the U.S. Securities and Exchange Commission.  Readers are cautioned that actual results may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. In addition, readers are cautioned that any estimates, forecasts or projections contained in this presentation or as may be discussed by Company management or its agents have been prepared by Company management in good faith on a basis believed to be reasonable. However, such estimates, forecasts and projections involve significant elements of subjective judgment and analysis and no representation can be made as to their attainability. No representation or warranty (express or implied) is made or is to be relied upon as a promise or representation as to the future performance of the Company. Readers are cautioned that such estimates, forecasts or projections have not been audited and have not been prepared in conformance with generally accepted accounting principles.

  3. Flagship: Dario Personalized Smart Meter for Diabetes Almost 10% of Americans today 1 in 3 American adults by 2050 The 5th leading cause of death in the world www.mydario.com

  4. Medical Companies HaveSpent Millions To Improve This Pack www.mydario.com

  5. Patients Still Have to Manage Their Own Condition Most of the Time 4 hours 8,756 Hours www.mydario.com

  6. To Manage Diabetes Effectively You Need a Combination of: Information Tools Motivation www.mydario.com

  7. Value to Patients Smart Meter Simple to use, Smart Meter™ Plugs into smartphonePocket-sized all-in-one Knowledge is empowering Personal pattern recognition & all information you need Knowledge Tools Information Motivation Support You’re not alone Peer & Professional support www.mydario.com

  8. Value to Payers Better testing & compliance Savings Better care & prevention = = www.mydario.com

  9. Value to Supporters Easier monitoring & remote support • Parents & children • Adults & older parents • Caregivers & PWDs www.mydario.com

  10. A Growing Market $27b (Up 170%) $12b 2022 2013 www.mydario.com

  11. Competitors Devices in the Market www.mydario.com

  12. Competitors Apps in the Market www.mydario.com

  13. The Only Personalized Smart Meter  Compact  Tiny blood sample  Highly accurate  All-in-one device  Automatically log & monitor  Actionable alerts  A1C estimates www.mydario.com

  14. Major Milestones 2014 2013 Q3 Q1 Q2 Q3 Q4 Q4    Device Soft Launch iPhone (UK, Italy, NZ) Europe & ROW App Launch CE Mark  Launch (Australia and Netherlands)  FDA Submission Continuous work with FDA US 2015 Q1 Q3 Q4 Q2 Europe & ROW Launch (Expansion in Europe, Canada) www.mydario.com Launch US

  15. Q2/Q3 Global reach (PwD coverage – 6.5M) # 0.2 2.3 4 Current PwD (Millions)

  16. 2015 Global reach (6.5M -> 49M) 1 10 26 0.2 3 3 2.3 4 # ? Dario PwD (Millions)

  17. Dario Direct Via Distributors B2B Sales Force B2C Digital Marketing App Users Healthcare Professionals www.mydario.com

  18. Soft Launch Examine Execution Capabilities • Improve compliance • Improves A1C Product • Manufacturing • Increase inventory on demand • Smooth delivery & support Supply chain • Sales/Marketing strategy works • CPA (Cost per acquisition) • Testimonials Sales & Marketing www.mydario.com

  19. Users feedback – www.mydario.com

  20. Multiple Potential Revenue Streams • Out of pocket & reimbursement • Disposable Strips (razorblade model) Device & Disposables • Healthcare professionals - licenses • Payer risk-management & cost reduction Software Platform • Clinical studies, trial recruitment • Partnerships Data Monetization www.mydario.com

  21. Clinical Studies Highest quality of clinical standards • Accuracy • Compliant with new standard • Usability Study -240 Patients • 89% claimed they will switch overnight www.mydario.com

  22. Comprehensive Intellectual Property 1 9 Patents : granted pending Core technology – device/smartphone integration Device design Software design In addition: Utility Model (1 granted) 8 9 1 4 4 3 www.mydario.com

  23. Why Dario  Why Now www.mydario.com

  24. Experienced Management Team 20 years of experience in building product organizations – from Design to commercialization. Formerly with Amdocs (NYSE: DOX) and Nokia-Siemens. Erez Raphael CEO & President BOD Director Gadi Levin CFO Seasoned executive with significant experience in publicly listed companies, capital market financings, accounting and financial management. Shosh Friedman VP Clinical and Regulatory Affairs (FRAP RAC) Former SVP Clinical and Regulatory Affairs at Given Imaging (NASDAQ:GIVN). More than 20 years in clinical, regulatory affairs and QA systems. • Entrepreneur and patient advocate who has dedicated his career to using technology to improve health and happiness. President of Diabetes Daily, a leading online community and educational platform. David Edelman Director Product Strategy • Entrepreneur and patient advocate who has dedicated his career to using technology to improve health and happiness. President of Diabetes Daily, a leading online community and educational platform. Over 16 years of executive leadership in the Medical Device Industry. He has extensive experience in global strategic marketing, business development, and clinical development knowledge. Eran Kurman VP, Global Strategy Over 16 years of executive leadership in the Medical Device Industry. He has extensive experience in global strategic marketing, business development, and clinical development knowledge. Dror Bacher VP, R&D More than 15 years of software business experience, including managing positions in product development at both mobile and semi-conductor companies. www.mydario.com

  25. Board of Directors Oren Fuerst, PhD Chairman & Co-Founder Seasoned entrepreneur and investor. Founder of Tevel Global & Strategic Models Former faculty Columbia Business School. Extensive experience in medical devices and data management Malcolm Hoenlein Director CEO, Executive Vice-Chairman, Conference of Major American Jewish Organizations. Director, Council of Foreign Relations Dennis McGrath Director Currently serves as President, CFO and board director of PhotoMedex, Inc. (NasdaqGS: PHMD,) joining the company in 2000 World-renowned urologist and researcher. Co-founded numerous technology initiatives, including MediData Solutions (NASDAQ:MDSO) the largest clinical trials data management company. Dr. Steven Kaplan Director Prof. Richard Stone Director Serves on the board of directors of multiple technology companies, including Powermat, Espro-Accoustiguide Group, Wellsense Technologies, NanoX Imaging and Check-Cap. Cofounded Lev Pharmaceuticals, Inc. which was sold to ViroPharma in 2008 for nearly $450 million in upfront consideration. Rami Yehudiha Director Marketing and advertising executive. From 2004 to the present, he has served as the Founder and Chief Executive Officer of LEAD, a top ten Israeli advertising firm. From 1997 to 2003, he served as the Chief Executive Officer at Ogilvy One Israel, a part of the WPP Group. www.mydario.com

  26. Scientific Advisory Board Head of Diabetes Unit and Research Center, Hadassah Medical Center; Israel National Council of Diabetes of the Israel Ministry of Health; President, Israel Diabetes Research Group. Prof Itamar Raz, MD Head of SAB Prof Itamar Raz, MD Head of SAB Has lived with type 1 diabetes since 1985 acknowledged as the 2014 Diabetes Educator of the Year by the American Association of Diabetes Educators. Known for his globally-available coaching services at IntegratedDiabetes.com. Gary Scheiner CDE MS Dr. William Polonsky PhD An internationally recognized expert in the behavioral aspects of diabetes management. Co-founded the Behavioral Diabetes Institute He is author of numerous books, including the famed Diabetes Burnout: What to Do When You Can’t Take It Anymore. Dietitian and diabetes educator for nearly thirty-five years. Owner of consulting practice, Hope Warshaw Associates, LLC,. Her work today spans from corporate consulting to consumer and professional writing and individual diabetes and weight management counseling. Hope Warshaw MMSc RD CDE BC-ADM Former Senior Medical Advisor at Eli Lilly & Company, has held teaching positions at Ohio University and Northeastern Ohio Universities College of Medicine, as well as served as President or Chair of American Diabetes Association, American Association of Clinical Endocrinologists, Ohio River Chapter, and the Ohio Diabetes Prevention and Control Program Dr. Paul Rosman DO FACP FACE FACOI Dr. Paolo Pozzilli MD Professor of Endocrinology and Metabolic Diseases, Head of Department at the University Campus Bio-Medico in Rome, Italy in charge of the Post-Graduate School and PhD program in Endocrinology and Diabetes. He is also Professor of Diabetes Research at St.Bartholomew’s and the London School of Medicine. Professor of Medicine, Endocrinologist and Angiologist at the Munich Diabetes Research Group in Germany. Has developed his career in both Munich, and at the Joslin Diabetes Center at Boston in USA. Dr. Eberhard Standl MD www.mydario.com

  27. Thank You. Thriving with Diabetes, Together Thriving with Diabetes In the Health Era

More Related